VAXASSIST
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98142108
- Registration number
- 7708072
- Mark type
- Stylized text
- Filed
- 21 Aug 2023
- Published for opposition
- 07 May 2024
- Registered
- 25 Feb 2025
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing wellness services in the field of vaccine administration; Providing wellness services to patients and caregivers, namely, personal health assessments regarding vaccine eligibility, vaccine maintenance schedules, and vaccine recommendations; Medical counseling services in the field of vaccine eligibility and management, namely, providing vaccine recommendations and vaccine maintenance scheduling reminders to patients and caregivers via an interactive website or mobile application; Medical information services provided via an interactive website or mobile application, namely, providing information to patients and caregivers in the field of vaccine eligibility, scheduling, and vaccine dispensary locations
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 28 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2024 — USE AMENDMENT FILED
- 05 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 21 Nov 2024 — SOU EXTENSION 1 GRANTED
- 21 Nov 2024 — SOU EXTENSION 1 FILED